Related by context. Frequent words. (Click for all words.) 72 include LibiGel ® 70 Genitope Corporation 70 candidate brentuximab vedotin 70 Locteron ® 69 Initiates Phase II 68 PEG PAL PEGylated recombinant 68 www.vivus.com 67 Therapeutic Competitors 67 Inc Therapeutic Competitors 67 sodium Injection 66 Completes Enrollment 66 Receives Orphan Drug Designation 66 Panzem R 66 Presents Positive 66 GVAX R 66 Inc. Nasdaq IMGN 66 phenylalanine ammonia lyase 65 please visit http:/www.supergen.com 65 Enrolls First 65 Inc. Nasdaq VVUS 65 Patient Enrollment 64 Inc. Nasdaq SUPG 64 developing Zerenex TM 64 Meets Primary Endpoint 64 Exploit collaboration 63 Initiates Phase 63 Nasdaq ALTH 63 Transcept Pharmaceuticals 63 inflammatory autoimmune diseases 63 Welcomes Analyst Initiation 63 Files Shelf Registration Statement 63 Takeda Kyowa Hakko Kirin 63 Ariba logo AribaLIVE 63 www.combinatorx.com 62 visit www.PAREXEL.com 62 MATERIALLY FROM ANY FUTURE 62 www.syntapharma.com 62 personalized immunotherapy 62 Inc. NASDAQ MBLX 62 commercializing therapeutic 62 Attracting Bullish Investors 62 PLK1 SNALP 62 Announces FDA Clearance 62 Nasdaq ENMD 62 www.patheon.com 62 NASDAQ CRXL 62 BioGlue R 61 Q2 Loss Narrows 61 www.polymedix.com 61 Inc. NASDAQ TRGT 61 CONTAINS FORWARD LOOKING STATEMENTS 61 Urigen Pharmaceuticals Inc. 61 refractory chronic lymphocytic 61 Commences Phase 61 www.hanabiosciences.com 61 Nasdaq ADLR 61 Q2 Loss Widens 61 Inc. NASDAQ MRNA 61 R bortezomib 61 Biolex Therapeutics 61 By Neil Osterweil 61 PRNewswire FirstCall Peregrine Pharmaceuticals 61 MKC# 61 Cerus Corporation 61 Bayhill Therapeutics 61 www.vical.com 61 AnalogicTech logo 61 Kuvan R 61 Genasense R oblimersen 61 R sorafenib tablets 61 NASDAQ SCLN 61 MacuSight 61 commercializes biotherapeutics 61 Nasdaq ENZN 61 Inc. Nasdaq TRMS 61 Pivotal Phase 60 Company Nasdaq PRGO 60 male hypogonadism licensed 60 NASDAQ MCHP 60 VIA Pharmaceuticals 60 phenylketonuria PKU developed 60 fibrosis IPF 60 http:/www.nabi.com 60 www.aveopharma.com 60 Jumps Higher 60 Surgical Adhesive 60 candidates bavituximab 60 www.delcath.com 60 DRRX 60 www.caliperLS.com 60 Q3 Loss Narrows 60 Pharmion Corporation 60 addressing idiopathic pulmonary 60 YOU IN RELIANCE 60 www.twitter.com otcadvisors 60 www.holliseden.com 60 Entereg R 60 Recombinant Human 60 BioMarin develops 60 Aradigm Corporation 60 Crucell NV Euronext